Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine

被引:41
作者
Heidbreder, C
Shoaib, M
Shippenberg, TS
机构
[1] National Institute of Health (NIH), National Institute on Drug Abuse, Preclinical Pharmacology Laboratory, Baltimore, MD 21224
关键词
cocaine; enkephalin; delta-opioid receptor; naltrindole; sensitization;
D O I
10.1016/0014-2999(95)00815-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was designed to determine whether the selective delta-opioid receptor antagonist naltrindole hydrochloride can prevent the expression and development of sensitization to the locomotor-activating effects of cocaine. Rats were sensitized to the motor stimulant effects of cocaine (20 mg/kg i.p. x 3 days). 48 h after withdrawal of pretreatment, rats were pretreated with naltrindole (0.1-1.0 mg/kg s.c.) or its vehicle and 15 min later challenged with either saline or the sensitizing dose of cocaine. In a second set of experiments, naltrindole (0.1-1.0 mg/kg s.c.) or its vehicle were given in combination with either saline or cocaine (20 mg/kg i.p.) for 3 days. Activity in response to saline and to cocaine (20 mg/kg i.p.) was assessed on days 4 and 5, respectively. Additional experiments determined whether naltrindole prevents the development of sensitization to the locomotor-activating effects of nicotine: naltrindole (0.3, 1.0 mg/kg s.c.) or its vehicle were given in combination with nicotine (0.6 mg/kg s.c.) for 3 days. Naltrindole blocked the development but not expression of sensitization to the locomotor-activating effects of cocaine. In contrast, naltrindole failed to modify nicotine-induced sensitization in nicotine-treated animals. These data suggest that delta-opioid receptors are involved in the development but not expression of behavioral sensitization to cocaine.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 55 条
[1]   INVOLVEMENT OF CENTRAL MU-OPIOID AND DELTA-OPIOID RECEPTORS IN MEDIATING THE REINFORCING EFFECTS OF BETA-ENDORPHIN IN THE RAT [J].
BALSKUBIK, R ;
SHIPPENBERG, TS ;
HERZ, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 175 (01) :63-69
[2]   OPIOID DELTA AGONISTS AND ENDOGENOUS ENKEPHALINS INDUCE DIFFERENT EMOTIONAL REACTIVITY THAN MU AGONISTS AFTER INJECTION IN THE RAT VENTRAL TEGMENTAL AREA [J].
CALENCOCHOUKROUN, G ;
DAUGE, V ;
GACEL, G ;
FEGER, J ;
ROQUES, BP .
PSYCHOPHARMACOLOGY, 1991, 103 (04) :493-502
[3]  
CLARKE PBS, 1988, J PHARMACOL EXP THER, V246, P701
[4]   LACK OF TOLERANCE TO NICOTINE-INDUCED DOPAMINE RELEASE IN THE NUCLEUS ACCUMBENS [J].
DAMSMA, G ;
DAY, J ;
FIBIGER, HC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 168 (03) :363-368
[5]   COMPARISON OF THE BEHAVIORAL-EFFECTS INDUCED BY ADMINISTRATION IN RAT NUCLEUS ACCUMBENS OR NUCLEUS CAUDATUS OF SELECTIVE MU AND DELTA OPIOID-PEPTIDES OR KELATORPHAN AN INHIBITOR OF ENKEPHALIN-DEGRADING-ENZYMES [J].
DAUGE, V ;
ROSSIGNOL, P ;
ROQUES, BP .
PSYCHOPHARMACOLOGY, 1988, 96 (03) :343-352
[6]   EFFECT OF INHIBITING ENKEPHALIN CATABOLISM IN THE VTA ON MOTOR-ACTIVITY AND EXTRACELLULAR DOPAMINE [J].
DAUGE, V ;
KALIVAS, PW ;
DUFFY, T ;
ROQUES, BP .
BRAIN RESEARCH, 1992, 599 (02) :209-214
[7]  
DEVINE D P, 1990, Society for Neuroscience Abstracts, V16, P930
[8]  
DEVINE DP, 1993, J PHARMACOL EXP THER, V266, P1236
[9]  
DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274
[10]  
DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067